Doctor of Philosophy - PhD (Application of Artificial Intelligence in Healthcare)
2020 - 2025
University of Oxford
Oxford / Said Business School Artificial Intelligence Programme (Artificial Intelligence)
2019 - 2019
Erasmus University Rotterdam
Minor (Geneeskunde)
2011 - 2011
Erasmus University Rotterdam
(Zorg Management)
2010 - 2011
The Open University
MBA
1991 - 1994
Delft University of Technology
MSc. (Electrical Engineering)
1983 - 1989
Mark Bloemendaal's Skills
Management Consulting
New Business Development
Business Strategy
Entrepreneurship
Change Management
Innovation Management
Interim Management
Signal Processing
Dutch
Product Development
Mark Bloemendaal's Summary
Mark Bloemendaal, based in Utrecht, UT, NL, is currently a CEO - Founder at Angiogenesis Analytics, bringing experience from previous roles at NLC - The Healthtech Venture Builder, LivAssured BV, SmartRollout and Implementation IQ. Mark Bloemendaal holds a 2020 - 2025 Doctor of Philosophy - PhD in Application of Artificial Intelligence in Healthcare @ Utrecht University. With a robust skill set that includes Management Consulting, New Business Development, Business Strategy, Entrepreneurship, Change Management and more, Mark Bloemendaal contributes valuable insights to the industry. Mark Bloemendaal has 4 emails and 2 mobile phone numbers on RocketReach.